Hexaxim 0.5 ml/prefilled syringe belongs to the generic category of Diphtheria + Tetanus + Pertussis + Hepatitis B + Polio + HIB. This medicine should be used according to a doctor's advice. We have provided detailed information about the uses, dosage, effectiveness, side effects, precautions, drug interactions, storage conditions, and other important details of Hexaxim 0.5 ml/prefilled syringe. Our goal is to present essential medicine information in one place for patients, caregivers, and healthcare professionals. To better understand Diphtheria + Tetanus + Pertussis + Hepatitis B + Polio + HIB and ensure the safe use of this medicine, please read the information below carefully and consult a healthcare professional when necessary.

/ 0.5 ml prefilled syringe
Hexaxim 0.5 ml/prefilled syringe may be available as a prescription or over-the-counter medicine, depending on local regulations and medical recommendations. It is used for the treatment and management of specific conditions or symptoms. The way this medicine is used may vary depending on the patient's condition and the advice of a healthcare provider. Detailed information about the approved uses, therapeutic applications, and other relevant details of Hexaxim 0.5 ml/prefilled syringe is provided below to help users gain a clear understanding of this medicine.
Hexaxim is indicated for primary and booster vaccination of infants and toddlers from six weeks to 24 months of age against diphtheria, tetanus, pertussis, Hepatitis B, poliomyelitis and invasive diseases caused by Haemophilus influenzae type.Primary vaccination: The primary vaccination ... Read moreHexaxim is indicated for primary and booster vaccination of infants and toddlers from six weeks to 24 months of age against diphtheria, tetanus, pertussis, Hepatitis B, poliomyelitis and invasive diseases caused by Haemophilus influenzae type.Primary vaccination: The primary vaccination schedule consists of three doses of 0.5 ml (such as 6, 10, 14 weeks; 2, 3, 4 months; 3, 4, 5 months; 2, 4, 6 months) to be administered at intervals of at least four weeks, in accordance with official recommendations. All vaccination schedules including the Expanded Program on Immunisation (at 6, 10, 14 weeks of age) can be used whether or not a dose of Hepatitis B vaccine has been given at birth
Primary Vaccination: Three injections at an interval of one to two months (at least four weeks apart).Booster: At least 6 months after the last dose of first course. This vaccine should be used according to the local vaccination programme.This should be administered intramuscularly. The recommended injection sites are generally the anterolateral aspect of the upper thigh in infants and toddlers and the deltoid muscle in older children. The intradermal or intravascular route must not be used.; ensure that the needle does not penetrate a blood vessel. Separate syringes, separate injection sites and preferably separate limbs must be used in case of the concomitant administration with other vaccines.
Serious Allergic reactions (anaphylactic reaction): Difficulty in breathing, blueness of tongue/lips, a rash, swelling of face/throat, sudden and dizziness, loss of consciousness, accelerated heart rate with respiratory disorders. Serious allergic reactions are a rare possibility (may up to 1 in 1,000 people) after receiving this vaccine. Other side effects:
Very common: Anorexia, crying, somnolence, vomiting, pain redness and swelling at injection site, irritability, Fever
Common side effects: Prolonged crying, diarrhoea, induration
Uncommon side effects: Allergicreaction, lump at injection site, High fever.
Vaccination must be postponed in cases of moderate or severe febrile and/or acute disease; the administration of Hexaxim must be carefully considered in individuals who have a history of serious or severe reactions within 48 hours following administration of a vaccine containing similar components. As with all injectable vaccines, the vaccine must be administered with caution to subjects with thrombocytopenia or a bleeding disorder since bleeding may occur following an intramuscular administration. If any of the following events are known to have occurred after receiving any pertussis-containing vaccine, the decision to give further doses of pertussis containing vaccine should be carefully considered:
The temperature of ≥40°C within 48 hours not due to another identifiable cause;
Collapse or shock-like state (hypotonic-hyporesponsive episode) within 48 hours of vaccination;
Persistent, inconsolable crying lasting ≥ 3 hours, occurring within 48 hours of vaccination;
Convulsions with or without fever, occurring within 3 days of vaccination. Take special care in case of Guillain Barré Syndrome, Brachial neuritis, acute or chronic renal insufficiency, epilepsy.
Vaccines, Anti-sera & Immunoglobulin
Keep out of the reach and sight of children. Store at +2°C to +8°C. Transportation should also be at +2°C to +8 °C. Do not freeze. Discard solution if frozen. Protect from light.
Data Source: Data source of Indications and Usages, Pharmacology, Dosage & Administration, Drug Interactions, Side Effects, Use during Pregnancy & Lactation, Precautions & Warnings, Use in Special Populations, Therapeutic Class, and Storage Conditions is the concerned medicine company or respective organization.
The information provided on All Samadhan is intended for general informational purposes only and is prepared based on our best practices. It is not a substitute for professional medical advice, diagnosis, or treatment. While we strive to keep the information accurate and up to date, we do not guarantee its completeness or accuracy. The absence of specific information or warnings about any medicine or service should not be considered as an assurance or endorsement by All Samadhan. All Samadhan shall not be held responsible for any consequences arising from the use of this information. We strongly recommend consulting a qualified healthcare professional or physician for any medical concerns, questions, or clarifications.All Samadhan is a digital healthcare software platform operated by MS Genius Experts. We provide technology solutions for pharmacies and healthcare providers; we are not a direct seller or dispenser of prescription medicines

N:B-All Samadhan is a digital healthcare software platform operated by MS Genius Experts. We provide technology solutions for pharmacies and healthcare providers; we are not a direct seller or dispenser of prescription medicines"
Copyright © All Samadhan - Operated by M/S. Genius Experts | All Rights Reserved
DBID
Registration ID: 176322642
Trade License: TRAD/DNCC/040904/2023